Duplicate publication bias weakens the validity of meta-analysis of immunosuppression after transplantation

Duplicate publication can introduce significant bias into a meta-analysis if studies are inadvertently included more than once. Many studies are published in more than one journal to maximize readership and impact of the study findings. Inclusion of multiple publications of the same study within a meta-analysis affords inappropriate weight to the duplicated data if reports of the same study are not linked together. As studies which have positive findings are more likely to be published in multiple journals this leads to a potential overestimate of the benefits of an intervention. Recent advances in immunosuppression strategies following liver transplantation have led to many studies investigating immunosuppressive regimes including immunosuppression monotherapy. In this letter we focus on a recently published meta-analysis by Lan et al investigating studies assessing immunosuppression monotherapy for liver transplantation. The authors claim to have identified fourteen separate randomised studies investigating immunosuppression monotherapy. Seven of the references appear to relate to only three studies which have been subject to duplicate publication. Several similarities can be identified in each of the duplicate publications including similar authorship, identical immunosuppression regimes, identical dates of enrolment and citation of the original publication in the subsequent manuscripts. We discuss the evidence of the duplicate publication inclusion in the meta-analysis.

[1]  Y. Soon,et al.  Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma: An Updated Meta-Analysis and Meta-Regression of Randomized Trials. , 2018, International Journal of Radiation Oncology, Biology, Physics.

[2]  Wei Zeng,et al.  Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. , 2014, World journal of gastroenterology.

[3]  Jun Li,et al.  Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials , 2014, Hepatology International.

[4]  S. Knight,et al.  Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta‐analysis , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  G. Otto,et al.  Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded Trial , 2010, Transplantation.

[6]  E. Cholongitas,et al.  Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  G. Sgourakis,et al.  Corticosteroid‐free immunosuppression in liver transplantation: a meta‐analysis and meta‐regression of outcomes , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  P. Thuluvath,et al.  Steroid avoidance in liver transplantation: Meta‐analysis and meta‐regression of randomized trials , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  G Otto,et al.  Tacrolimus Monotherapy Without Steroids After Liver Transplantation – A Prospective Randomized Double‐Blinded Placebo‐Controlled Trial , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  A. Dhillon,et al.  Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis , 2006, Transplant infectious disease : an official journal of the Transplantation Society.

[11]  L. Belli,et al.  Early cyclosporine monotherapy in liver transplantation: A 5‐year follow‐up of a prospective, randomized trial , 1998, Hepatology.

[12]  C. Sansalone,et al.  Early steroid withdrawal in liver transplant patients: final report of a prospective randomized trial. , 1997, Transplantation proceedings.

[13]  F. Romani,et al.  Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. , 1994, Transplantation proceedings.

[14]  S. Wigmore,et al.  Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. , 2018, The Cochrane database of systematic reviews.